NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
NovaBridge Biosciences
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 7, 2026
$1.30+0.04 (+3.17%)
Close on Oct 19, 2026
NovaBridge Biosciences statistics
Financials through Dec 31, 2025, price-based ratios appear once a share price is available, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | NovaBridge Biosciences | Industry median |
|---|---|---|
| Market Cap | CN¥1.00B | CN¥1.00B |
| Enterprise Value | CN¥1.00B | CN¥1.59B |
Efficiency
| Measure | NovaBridge Biosciences | Industry median |
|---|---|---|
| Employee Count | 220 | 767 |
Shares
| Measure | NovaBridge Biosciences | Industry median |
|---|---|---|
| Shares Outstanding | 265,378,000 | 373,322,000 |
| Shares Change (YoY) | 18.0% | 3.69% |
| Float | 190,423,000 | 324,662,000 |
| Shares Held by Insiders | 28.2% | 25.5% |
| Shares Held by Institutions | 9.30% |
Calculated by StockData from NovaBridge Biosciences's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.